Amniotic membrane mesenchymal stromal cell-derived secretome in the treatment of acute ischemic stroke: A case report

doi:10.12998/wjcc.v11.i27.6543

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1275)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

WORD

HTML

757

Figures (1-4)

182

Sum=995

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

143

Sum=228

Sep 26, 2023 (publication date) through May 20, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Sep 26, 2023; 11(27): 6543-6550
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6543

Full Size Figure Download Figure

Figure 3 Neurological function before and after mesenchymal stromal cell-secretome transplantation. A: National Institutes of Health Stroke Scale (NIHSS) score; B: Barthel index (BI) score.

Citation: Lin FH, Yang YX, Wang YJ, Subbiah SK, Wu XY. Amniotic membrane mesenchymal stromal cell-derived secretome in the treatment of acute ischemic stroke: A case report. World J Clin Cases 2023; 11(27): 6543-6550
URL: https://www.wjgnet.com/2307-8960/full/v11/i27/6543.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i27.6543